Willow Biosciences (WLLW) Stock Price, News & Analysis

Company Overview

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Key Stats

• Today's Range: C$0.03 to C$0.04
• 50-Day Range: C$0.01 to C$0.04
• 52-Week Range: C$0.01 to C$0.15
• Volume: 1.09 million shs
• Average Volume: 685,866 shs
• Market Capitalization: C$5.07 million
• P/E Ratio: N/A
• Dividend Yield: 7.35%
• Price Target: N/A
• Consensus Rating: N/A

WLLW Stock Analysis - Frequently Asked Questions

How have WLLW shares performed this year?

Willow Biosciences' stock was trading at C$0.07 on January 1st, 2025. Since then, WLLW stock has decreased by 46.2% and is now trading at C$0.04.
View the best growth stocks for 2025 here.

How do I buy shares of Willow Biosciences?

Shares of WLLW stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Willow Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Willow Biosciences investors own include Canopy Growth (CGC), Dynavax Technologies (DVAX), Lightspeed Commerce (LSPD), VEON (VEON), Vaxart (VXRT), BlackBerry (BB) and NightHawk Biosciences (NHWK).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:WLLW
• CIK: N/A
• Web: www.willowbio.com
• Phone: 403 910 5140
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 1.82
• P/E Growth: N/A
• Net Income: C$-7,917,873.68
• Net Margins: -268.91%
• Pretax Margin: N/A
• Return on Equity: -602.73%
• Return on Assets: -74.79%

Debt

• Debt-to-Equity Ratio: 902.05
• Current Ratio: 0.80
• Quick Ratio: 19.71

Sales & Book Value

• Annual Sales: C$2.94 million
• Price / Sales: 1.72
• Cash Flow: C$0.04 per share
• Price / Cash Flow: 0.83
• Book Value: C$0.00 per share
• Price / Book: 25.33

Miscellaneous

• Outstanding Shares: 144,847,000
• Free Float: N/A
• Market Cap: C$5.07 million
• Optionable: Not Optionable
• Beta: 1.13